Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Enrichment of Antigen-Specific Class-Switched B Cells from Individuals Naturally Immunized by Infection with Group A Streptococcus.

Lamb CL, Price E, Field KP, Dayton C, McIndoo ER, Katahira EJ, Stevens DL, Hobdey SE.

mSphere. 2019 Nov 6;4(6). pii: e00598-19. doi: 10.1128/mSphere.00598-19.

2.

Enzymatic Modification of Polyamide for Improving the Conductivity of Water-Based Multilayer Nanocoatings.

Jordanov I, Stevens DL, Tarbuk A, Magovac E, Bischof S, Grunlan JC.

ACS Omega. 2019 Jul 11;4(7):12028-12035. doi: 10.1021/acsomega.9b01052. eCollection 2019 Jul 31.

3.

Experimental Colitis Enhances the Rate of Antinociceptive Tolerance to Morphine via Peripheral Opioid Receptors.

Komla E, Stevens DL, Zheng Y, Zhang Y, Dewey WL, Akbarali HI.

J Pharmacol Exp Ther. 2019 Sep;370(3):504-513. doi: 10.1124/jpet.119.256941. Epub 2019 Jun 27.

PMID:
31248978
4.

Editorial: Pathogenesis and host response in the era of modern diagnostics: let's continue the basics.

Stevens DL, Bryant AE.

Curr Opin Infect Dis. 2019 Jun;32(3):187-190. doi: 10.1097/QCO.0000000000000551. No abstract available.

PMID:
30950856
5.

Characterization of 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(indole-7-carboxamido)morphinan (NAN) as a Novel Opioid Receptor Modulator for Opioid Use Disorder Treatment.

Obeng S, Jali A, Zheng Y, Wang H, Schwienteck KL, Chen C, Stevens DL, Akbarali HI, Dewey WL, Banks ML, Liu-Chen LY, Selley DE, Zhang Y.

ACS Chem Neurosci. 2019 May 15;10(5):2518-2532. doi: 10.1021/acschemneuro.9b00038. Epub 2019 Feb 21.

PMID:
30758946
6.

The effects of iclaprim on exotoxin production in methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.

Bryant AE, Gomi S, Katahira E, Huang DB, Stevens DL.

J Med Microbiol. 2019 Mar;68(3):456-466. doi: 10.1099/jmm.0.000929. Epub 2019 Jan 24.

7.

Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.

Zheng Y, Obeng S, Wang H, Jali AM, Peddibhotla B, Williams DA, Zou C, Stevens DL, Dewey WL, Akbarali HI, Selley DE, Zhang Y.

J Med Chem. 2019 Jan 24;62(2):561-574. doi: 10.1021/acs.jmedchem.8b01158. Epub 2019 Jan 11.

8.

Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus.

Katahira EJ, Davidson SM, Stevens DL, Bolz DD.

J Med Microbiol. 2019 Feb;68(2):255-262. doi: 10.1099/jmm.0.000905. Epub 2018 Dec 17.

9.

Loss of protein synthesis quality control in host-restricted organisms.

Melnikov SV, van den Elzen A, Stevens DL, Thoreen CC, Söll D.

Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):E11505-E11512. doi: 10.1073/pnas.1815992115. Epub 2018 Nov 19.

10.

Sub-lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro.

Aldape MJ, Rice SN, Field KP, Bryant AE, Stevens DL.

J Med Microbiol. 2018 Dec;67(12):1689-1697. doi: 10.1099/jmm.0.000852. Epub 2018 Oct 11.

11.

Structure-Activity Relationship Studies of 6α- and 6β-Indolylacetamidonaltrexamine Derivatives as Bitopic Mu Opioid Receptor Modulators and Elaboration of the "Message-Address Concept" To Comprehend Their Functional Conversion.

Obeng S, Wang H, Jali A, Stevens DL, Akbarali HI, Dewey WL, Selley DE, Zhang Y.

ACS Chem Neurosci. 2019 Mar 20;10(3):1075-1090. doi: 10.1021/acschemneuro.8b00349. Epub 2018 Sep 7.

PMID:
30156823
12.

Comparative efficacy of antibiotics in treating experimental Clostridium septicum infection.

Aldape MJ, Bayer CR, Rice SN, Bryant AE, Stevens DL.

Int J Antimicrob Agents. 2018 Oct;52(4):469-473. doi: 10.1016/j.ijantimicag.2018.07.009. Epub 2018 Sep 14.

13.

Nusinersen: A Treatment for Spinal Muscular Atrophy.

Claborn MK, Stevens DL, Walker CK, Gildon BL.

Ann Pharmacother. 2019 Jan;53(1):61-69. doi: 10.1177/1060028018789956. Epub 2018 Jul 16.

PMID:
30008228
14.

Methylation Products of 6β- N-Heterocyclic Substituted Naltrexamine Derivatives as Potential Peripheral Opioid Receptor Modulators.

Zheng Y, Obeng S, Wang H, Stevens DL, Komla E, Selley DE, Dewey WL, Akbarali HI, Zhang Y.

ACS Chem Neurosci. 2018 Dec 19;9(12):3028-3037. doi: 10.1021/acschemneuro.8b00234. Epub 2018 Jul 23.

PMID:
30001114
15.

Necrotizing Soft-Tissue Infections.

Stevens DL, Bryant AE.

N Engl J Med. 2018 Mar 8;378(10):971. doi: 10.1056/NEJMc1800049. No abstract available.

PMID:
29514033
16.

Necrotizing Soft-Tissue Infections.

Stevens DL, Bryant AE.

N Engl J Med. 2017 Dec 7;377(23):2253-2265. doi: 10.1056/NEJMra1600673. Review. No abstract available.

PMID:
29211672
17.

CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.

Gonek M, McLane VD, Stevens DL, Lippold K, Akbarali HI, Knapp PE, Dewey WL, Hauser KF, Paris JJ.

Brain Behav Immun. 2018 Mar;69:124-138. doi: 10.1016/j.bbi.2017.11.006. Epub 2017 Nov 13.

18.

Fidaxomicin reduces early toxin A and B production and sporulation in Clostridium difficilein vitro.

Aldape MJ, Packham AE, Heeney DD, Rice SN, Bryant AE, Stevens DL.

J Med Microbiol. 2017 Oct;66(10):1393-1399. doi: 10.1099/jmm.0.000580. Epub 2017 Sep 12.

PMID:
28893366
19.

Subinhibitory Dalbavancin Attenuates Exotoxin Production from Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus In Vitro.

Hobdey SE, Katahira EJ, Dockstader P, Davidson SM, Bond L, Bolz DD, Bryant AE, Stevens DL.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01090-17. doi: 10.1128/AAC.01090-17. Print 2017 Nov.

20.

Spontaneous C. septicum gas gangrene: A literature review.

Srivastava I, Aldape MJ, Bryant AE, Stevens DL.

Anaerobe. 2017 Dec;48:165-171. doi: 10.1016/j.anaerobe.2017.07.008. Epub 2017 Aug 2. Review.

PMID:
28780428
21.

Effects of delayed NSAID administration after experimental eccentric contraction injury - A cellular and proteomics study.

Bryant AE, Aldape MJ, Bayer CR, Katahira EJ, Bond L, Nicora CD, Fillmore TL, Clauss TR, Metz TO, Webb-Robertson BJ, Stevens DL.

PLoS One. 2017 Feb 28;12(2):e0172486. doi: 10.1371/journal.pone.0172486. eCollection 2017.

22.

Advances in the medical management of skin and soft tissue infections.

McClain SL, Bohan JG, Stevens DL.

BMJ. 2016 Dec 14;355:i6004. doi: 10.1136/bmj.i6004. Review.

PMID:
27974335
23.

6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand.

Williams DA, Zheng Y, David BG, Yuan Y, Zaidi SA, Stevens DL, Scoggins KL, Selley DE, Dewey WL, Akbarali HI, Zhang Y.

ACS Chem Neurosci. 2016 Aug 17;7(8):1120-9. doi: 10.1021/acschemneuro.6b00075. Epub 2016 Jun 15.

24.

Severe Group A Streptococcal Infections.

Stevens DL, Bryant AE.

In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes : Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016-.
2016 Feb 10.

25.

Impetigo, Erysipelas and Cellulitis.

Stevens DL, Bryant AE.

In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes : Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016-.
2016 Feb 10.

26.

A novel murine model of Clostridium sordellii myonecrosis: Insights into the pathogenesis of disease.

Aldape MJ, Bayer CR, Bryant AE, Stevens DL.

Anaerobe. 2016 Apr;38:103-110. doi: 10.1016/j.anaerobe.2016.01.004. Epub 2016 Jan 21.

27.

Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.

Fitting S, Stevens DL, Khan FA, Scoggins KL, Enga RM, Beardsley PM, Knapp PE, Dewey WL, Hauser KF.

J Pharmacol Exp Ther. 2016 Jan;356(1):96-105. doi: 10.1124/jpet.115.226407. Epub 2015 Nov 5.

28.

Variation in RBE for Survival of V79-4 Cells as a Function of Alpha-Particle (Helium Ion) Energy.

Tracy BL, Stevens DL, Goodhead DT, Hill MA.

Radiat Res. 2015 Jul;184(1):33-45. Epub 2015 Jun 29.

PMID:
26121227
29.

The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections.

Bryant AE, Bayer CR, Aldape MJ, Stevens DL.

Curr Opin Infect Dis. 2015 Jun;28(3):231-9. doi: 10.1097/QCO.0000000000000160. Review.

30.

Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands.

Yuan Y, Zaidi SA, Stevens DL, Scoggins KL, Mosier PD, Kellogg GE, Dewey WL, Selley DE, Zhang Y.

Bioorg Med Chem. 2015 Apr 15;23(8):1701-15. doi: 10.1016/j.bmc.2015.02.055. Epub 2015 Mar 6.

31.

Reply to Eljaaly et al.

Stevens DL.

Clin Infect Dis. 2015 Jun 1;60(11):1732. doi: 10.1093/cid/civ127. Epub 2015 Feb 24. No abstract available.

PMID:
25713185
32.

Sensitization of enteric neurons to morphine by HIV-1 Tat protein.

Fitting S, Ngwainmbi J, Kang M, Khan FA, Stevens DL, Dewey WL, Knapp PE, Hauser KF, Akbarali HI.

Neurogastroenterol Motil. 2015 Apr;27(4):468-80. doi: 10.1111/nmo.12514. Epub 2015 Feb 19.

33.

Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro.

Bancos S, Stevens DL, Tyner KM.

Int J Nanomedicine. 2014 Dec 24;10:183-206. doi: 10.2147/IJN.S72580. eCollection 2015.

34.

Reply to González del Castillo et al and Rashid and Kravitz.

Stevens DL.

Clin Infect Dis. 2015 Jan 1;60(1):172-4. doi: 10.1093/cid/ciu774. Epub 2014 Oct 8. No abstract available.

PMID:
25296663
35.

Cardiac myocyte dysfunction induced by streptolysin O is membrane pore and calcium dependent.

Bolz DD, Li Z, McIndoo ER, Tweten RK, Bryant AE, Stevens DL.

Shock. 2015 Feb;43(2):178-84. doi: 10.1097/SHK.0000000000000266.

36.

Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile.

Aldape MJ, Heeney DD, Bryant AE, Stevens DL.

J Antimicrob Chemother. 2015 Jan;70(1):153-9. doi: 10.1093/jac/dku325. Epub 2014 Aug 23.

37.

The influence of dose rate on the induction of chromosome aberrations and gene mutation after exposure of plateau phase V79-4 cells with high-LET alpha particles.

Stevens DL, Bradley S, Goodhead DT, Hill MA.

Radiat Res. 2014 Sep;182(3):331-7. doi: 10.1667/RR13746.1. Epub 2014 Aug 12.

PMID:
25117623
38.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.

Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC; Infectious Diseases Society of America.

Clin Infect Dis. 2014 Jul 15;59(2):e10-52. doi: 10.1093/cid/ciu444. Erratum in: Clin Infect Dis. 2015 May 1;60(9):1448. Dosage error in article text.

PMID:
24973422
39.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.

Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC.

Clin Infect Dis. 2014 Jul 15;59(2):147-59. doi: 10.1093/cid/ciu296. Epub 2014 Jun 18.

PMID:
24947530
40.

HALE and hearty: Toward more meaningful health measurement in the clinical setting.

Stine NW, Stevens DL, Braithwaite RS, Gourevitch MN, Wilson RM.

Healthc (Amst). 2013 Dec;1(3-4):86-90. doi: 10.1016/j.hjdsi.2013.07.003. Epub 2013 Aug 30. No abstract available.

PMID:
26249778
41.

Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis.

Hamilton SM, Bayer CR, Stevens DL, Bryant AE.

J Infect Dis. 2014 May 1;209(9):1429-35. doi: 10.1093/infdis/jit594. Epub 2013 Nov 11.

42.

Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity.

Yuan Y, Zaidi SA, Elbegdorj O, Aschenbach LC, Li G, Stevens DL, Scoggins KL, Dewey WL, Selley DE, Zhang Y.

J Med Chem. 2013 Nov 27;56(22):9156-69. doi: 10.1021/jm4012214. Epub 2013 Nov 7.

43.

Serious group a streptococcal infections.

Wong CJ, Stevens DL.

Med Clin North Am. 2013 Jul;97(4):721-36, xi-xii. doi: 10.1016/j.mcna.2013.03.003. Epub 2013 Apr 24. Review.

PMID:
23809722
44.

Staphylococcus aureus α-hemolysin promotes platelet-neutrophil aggregate formation.

Parimon T, Li Z, Bolz DD, McIndoo ER, Bayer CR, Stevens DL, Bryant AE.

J Infect Dis. 2013 Sep 1;208(5):761-70. doi: 10.1093/infdis/jit235. Epub 2013 May 22.

45.

Pregnancy-related group a streptococcal infections: temporal relationships between bacterial acquisition, infection onset, clinical findings, and outcome.

Hamilton SM, Stevens DL, Bryant AE.

Clin Infect Dis. 2013 Sep;57(6):870-6. doi: 10.1093/cid/cit282. Epub 2013 May 3. Review.

46.

Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile.

Aldape MJ, Packham AE, Nute DW, Bryant AE, Stevens DL.

J Med Microbiol. 2013 May;62(Pt 5):741-7. doi: 10.1099/jmm.0.056218-0. Epub 2013 Feb 21.

47.

Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.

Yuan Y, Elbegdorj O, Chen J, Akubathini SK, Zhang F, Stevens DL, Beletskaya IO, Scoggins KL, Zhang Z, Gerk PM, Selley DE, Akbarali HI, Dewey WL, Zhang Y.

J Med Chem. 2012 Nov 26;55(22):10118-29. doi: 10.1021/jm301247n. Epub 2012 Nov 9.

48.

Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.

Yuan Y, Li G, He H, Stevens DL, Kozak P, Scoggins KL, Mitra P, Gerk PM, Selley DE, Dewey WL, Zhang Y.

ACS Chem Neurosci. 2011 Jul 20;2(7):346-51. doi: 10.1021/cn2000348. Epub 2011 May 6.

49.

6β-N-heterocyclic substituted naltrexamine derivative NAP as a potential lead to develop peripheral mu opioid receptor selective antagonists.

Yuan Y, Stevens DL, Braithwaite A, Scoggins KL, Bilsky EJ, Akbarali HI, Dewey WL, Zhang Y.

Bioorg Med Chem Lett. 2012 Jul 15;22(14):4731-4. doi: 10.1016/j.bmcl.2012.05.075. Epub 2012 May 26.

50.

Cardiac dysfunction in StrepTSS: group A streptococcus disrupts the directional cardiomyocyte-to-macrophage crosstalk that maintains macrophage quiescence.

Li Z, Bryant AE, Parimon T, Stevens DL.

Cytokine. 2012 Jul;59(1):191-4. doi: 10.1016/j.cyto.2012.03.023. Epub 2012 Apr 23.

PMID:
22534112

Supplemental Content

Loading ...
Support Center